ImmuCell (ICCC) Competitors $4.41 -0.17 (-3.71%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ICCC vs. SGMT, ACTU, TSVT, STRO, CRBU, NKTX, CKPT, SCPH, ZURA, and CDTXShould you be buying ImmuCell stock or one of its competitors? The main competitors of ImmuCell include Sagimet Biosciences (SGMT), Actuate Therapeutics (ACTU), 2seventy bio (TSVT), Sutro Biopharma (STRO), Caribou Biosciences (CRBU), Nkarta (NKTX), Checkpoint Therapeutics (CKPT), scPharmaceuticals (SCPH), Zura Bio (ZURA), and Cidara Therapeutics (CDTX). These companies are all part of the "pharmaceutical products" industry. ImmuCell vs. Sagimet Biosciences Actuate Therapeutics 2seventy bio Sutro Biopharma Caribou Biosciences Nkarta Checkpoint Therapeutics scPharmaceuticals Zura Bio Cidara Therapeutics Sagimet Biosciences (NASDAQ:SGMT) and ImmuCell (NASDAQ:ICCC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, community ranking, institutional ownership, valuation, earnings, risk, profitability and dividends. Does the media favor SGMT or ICCC? In the previous week, Sagimet Biosciences had 1 more articles in the media than ImmuCell. MarketBeat recorded 1 mentions for Sagimet Biosciences and 0 mentions for ImmuCell. Sagimet Biosciences' average media sentiment score of 0.00 equaled ImmuCell'saverage media sentiment score. Company Overall Sentiment Sagimet Biosciences Neutral ImmuCell Neutral Do insiders & institutionals have more ownership in SGMT or ICCC? 87.9% of Sagimet Biosciences shares are owned by institutional investors. Comparatively, 13.5% of ImmuCell shares are owned by institutional investors. 17.6% of Sagimet Biosciences shares are owned by company insiders. Comparatively, 6.6% of ImmuCell shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, SGMT or ICCC? Sagimet Biosciences has a beta of 2.3, indicating that its share price is 130% more volatile than the S&P 500. Comparatively, ImmuCell has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Is SGMT or ICCC more profitable? Sagimet Biosciences has a net margin of 0.00% compared to ImmuCell's net margin of -15.99%. ImmuCell's return on equity of -15.32% beat Sagimet Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Sagimet BiosciencesN/A -23.63% -22.91% ImmuCell -15.99%-15.32%-8.81% Which has higher earnings & valuation, SGMT or ICCC? ImmuCell has higher revenue and earnings than Sagimet Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSagimet Biosciences$2M75.92-$27.88MN/AN/AImmuCell$23.84M1.65-$5.78M-$0.50-8.82 Do analysts recommend SGMT or ICCC? Sagimet Biosciences currently has a consensus price target of $23.00, suggesting a potential upside of 364.65%. Given Sagimet Biosciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe Sagimet Biosciences is more favorable than ImmuCell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sagimet Biosciences 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86ImmuCell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor SGMT or ICCC? ImmuCell received 95 more outperform votes than Sagimet Biosciences when rated by MarketBeat users. However, 96.30% of users gave Sagimet Biosciences an outperform vote while only 73.33% of users gave ImmuCell an outperform vote. CompanyUnderperformOutperformSagimet BiosciencesOutperform Votes2696.30% Underperform Votes13.70%ImmuCellOutperform Votes12173.33% Underperform Votes4426.67% SummarySagimet Biosciences beats ImmuCell on 10 of the 15 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get ImmuCell News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICCC vs. The Competition Export to ExcelMetricImmuCellDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.30M$2.51B$5.14B$9.08BDividend YieldN/A0.73%5.09%4.23%P/E Ratio-8.826.0790.0517.18Price / Sales1.6575.121,117.14116.99Price / CashN/A15.0543.0437.86Price / Book1.373.284.784.78Net Income-$5.78M$29.98M$120.31M$225.60M7 Day Performance-10.37%-1.55%-1.92%-1.23%1 Month Performance20.49%8.21%11.51%3.36%1 Year Performance-5.36%-21.46%30.61%16.60% ImmuCell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICCCImmuCellN/A$4.41-3.7%N/A-7.9%$39.30M$23.84M-8.8275Positive NewsGap DownSGMTSagimet Biosciences2.3237 of 5 stars$5.69+29.6%$23.00+304.2%-8.0%$174.51M$2M0.008Gap UpHigh Trading VolumeACTUActuate TherapeuticsN/A$8.88+3.0%N/AN/A$173.44MN/A0.0010Gap UpTSVT2seventy bio2.2124 of 5 stars$3.33+1.8%$9.00+170.3%-7.1%$171.80M$100.39M-1.76440Positive NewsSTROSutro Biopharma4.4638 of 5 stars$2.08-1.9%$11.13+434.9%-51.3%$171.52M$153.73M-1.32240CRBUCaribou Biosciences2.2043 of 5 stars$1.88-1.6%$10.20+442.6%-69.4%$170.24M$11.48M-1.16100Positive NewsNKTXNkarta2.7945 of 5 stars$2.34flat$15.00+541.0%-35.4%$165.13MN/A-1.24140Gap UpCKPTCheckpoint Therapeutics3.8163 of 5 stars$3.37-8.2%$10.33+206.6%+113.1%$164.56M$100,000.00-1.8310Insider TradeNews CoverageGap UpHigh Trading VolumeSCPHscPharmaceuticals3.2494 of 5 stars$3.28+2.8%$15.00+357.3%-43.6%$164.13M$13.59M-1.6830ZURAZura Bio3.2143 of 5 stars$2.50+9.6%$15.80+532.0%-52.8%$163.23MN/A0.003CDTXCidara Therapeutics3.6797 of 5 stars$23.00+0.5%$32.20+40.0%+54.8%$162.15M$63.90M-0.9090 Related Companies and Tools Related Companies SGMT Alternatives ACTU Alternatives TSVT Alternatives STRO Alternatives CRBU Alternatives NKTX Alternatives CKPT Alternatives SCPH Alternatives ZURA Alternatives CDTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ICCC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmuCell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ICCC Stock Alerts